Predictive Factors of Response to Phase II Cardiac Rehabilitation in Heart Failure With Reduced Ejection Fraction

Recruiting Observational Study
HFrEF - Heart Failure With Reduced Ejection Fraction Cardiac Rehabilitation Exercise Training Exercise Adaptations Exercise Intolerance Exercise Intervention
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 75
Sex
Any
Study type
Observational
Participants needed
62 (estimated)
Sponsor
Centre Hospitalier de Corbie · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Exercise intolerance, measured as peak oxygen consumption (VO₂peak) during exercise in patients with heart failure with reduced ejection fraction (HFrEF). Change in VO₂peak (ΔVO₂peak), which serves as a prognostic marker for HFrEF engaged in exercise based cardiac rehabilitation program (ExCR). Responders to ExCR generally show improved cardiac function but some patients with HFrEF do not respond …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Heart failure with reduced ejection fraction \< 40% * NYHA functional class ≥ II * Clinically stable for at least 6 weeks * On optimized medical therapy for at least 6 weeks * Prescription for phase II cardiac rehabilitation * BMI between 20-30 kg·m-² * Physical activity level…
Contacts

Pierre-Marie Leprêtre, professor

+33235148113

pierre-marie.lepretre@univ-rouen.fr

CONTACT